Kevin graduated from the University of Sussex with a BSc in Biology and a DPhil in Developmental Neurobiology. Kevin has nearly 20 years’ experience in the pharmaceutical industry, ranging from drug discovery teams at Knoll Pharmaceuticals and the University of Nottingham, through contract research organisations providing Hit-to-Lead screening services for Millennium Pharmaceuticals and Amgen, to biotech businesses developing technologies and reagents for the pharmaceutical industry.

He has a therapeutic background in CNS, metabolic, oncology and cardiovascular diseases. Central to his career has been a focus on Quality Assurance, demonstrated by his leading role in achieving ISO9001:2000 accreditation for screening services at BioFocus.